Search
for
Sort by
Research 301–330 of 345
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Taste disorders and alopecia in myasthenia gravis
- Androgens in SARS-CoV-2 Coronavirus Infections
- Кореляційний аналіз взаємозв’язку хронічних дерматозів із соматичною патологією та обґрунтування детоксикаційної терапії
- Finasteride-Induced Neuropsychiatric Reactions
- Therapeutic Intervention in Lichen Planus Pilar (LPP): Synergy of Low-Level Laser Therapy and Topical Corticosteroid
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- LB1053 Dysregulation of antioxidant enzyme PRDX5 in alopecia areata
- 0348 Adverse event reports of alopecia for sunscreen ingredients and branded products
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Atherogenesis: Estrogen Induction of Polysialylated nCAM (PSA-nCAM) Blocks Monocyte Capture by Vascular Endothelial Cells
- Topical minoxidil in the treatment of androgenetic alopecia in women.
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Diagnosis and Management of Glaucoma
- Nutraceuticals for Androgenetic Alopecia.
- Platelet-Rich Plasma Monotherapies for Androgenetic Alopecia: A Network Meta-Analysis and Meta-Regression Study
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Combination Therapy in Androgenetic Alopecia: A Network Meta-Analysis of Minoxidil and Other Pharmacological Agents
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- The Comparative Effects of Monotherapy with Topical Minoxidil, Oral Finasteride, and Topical Finasteride in Postmenopausal Women with Pattern Hair Loss: A Retrospective Cohort Study
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Optimal processing for proteomic genotyping of single human hairs
- Alopecia in Association with Lamotrigine Use
- Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia.
- Does smoking affect your skin?
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age